SKI Market

Indian Indices

Nifty

24,677.80 -30.60
(-0.12%)

Sensex

81,709.12 -56.74
( -0.07%)

Bank Nifty

53,509.50 -94.05
( -0.18%)

Nifty IT

44,716.05 -90.35
( -0.20%)

Global Indices

Nasdaq

19,859.77 159.05
(0.81%)

Dow Jones

44,642.52 -123.19
(-0.28%)

Hang Seng

19,865.85 305.41
(1.56%)

Nikkei 225

39,091.17 -304.43
(-0.77%)

Forex

USD-INR

84.71 0.00
(0.00%)

EUR-INR

89.34 0.33
(0.37%)

GBP-INR

107.84 0.40
(0.37%)

JPY-INR

0.56 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

532331

INE031B01049

282.5572901

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AJANTPHARM

41.91

35789.81

EPS(TTM)

Face Value()

Div & Yield %

68.36

1.8

Back

ajanta pharma ltd

Ajanta Pharma consolidated net profit rises 10.84% in the September 2024 quarter

Oct 28,2024

Net profit of Ajanta Pharma rose 10.84% to Rs 216.48 crore in the quarter ended September 2024 as against Rs 195.30 crore during the previous quarter ended September 2023. Sales rose 15.38% to Rs 1186.64 crore in the quarter ended September 2024 as against Rs 1028.44 crore during the previous quarter ended September 2023.

Particulars	Quarter Ended
	Sep. 2024	Sep. 2023	% Var.
Sales	1186.64	1028.44	15
OPM %	26.22	28.26	-
PBDT	324.63	309.65	5
PBT	290.24	275.94	5
NP	216.48	195.30	11

24,677.80 -30.60 (-0.12%)

81,709.12 -56.74 ( -0.07%)

53,509.50 -94.05 ( -0.18%)

44,716.05 -90.35 ( -0.20%)

19,859.77 159.05 (0.81%)

44,642.52 -123.19 (-0.28%)

19,865.85 305.41 (1.56%)

39,091.17 -304.43 (-0.77%)

84.71 0.00 (0.00%)

89.34 0.33 (0.37%)

107.84 0.40 (0.37%)

0.56 0.00 (0.12%)